评估下一代病毒生长试验作为HIV-1潜伏储存库测量替代方法的适用性
研究比较了6种下一代病毒生长试验与经典定量病毒生长试验(QVOA),使用5名抗逆转录病毒治疗抑制的HIV感染者和1名未感染对照者的单次白细胞分离样本,每个实验室检测盲法批次样本。下一代试验变异估计与QVOA相似,超灵敏读数报告更高的感染单位/百万值,批次内额外泊松变异为2.5倍,实验室间变异增至3.4倍,冻存未显著改变感染单位/百万值。结论谨慎支持下一代QVOAs作为更费力QVOAs的替代,具有更高灵敏度和动态范围。
要点
- 下一代QVOAs变异估计与经典QVOA相似,超灵敏读数报告更高感染单位/百万值。
- 批次内额外泊松变异为2.5倍(95%CI 2.1-3.5倍),实验室间变异增至3.4倍(95%CI 2.6-5.4倍)。
- 冻存与新鲜样本相比,感染单位/百万值变化为-18%(95%CI -52%至39%),无显著差异。
核心结论
- 数据谨慎支持下一代QVOAs作为更费力QVOAs的替代,提供更高灵敏度和动态范围。
研究设计与样本
- 比较6种下一代病毒生长试验与经典QVOA,使用5名抗逆转录病毒治疗抑制的HIV感染者和1名未感染对照者的单次白细胞分离样本,每个实验室检测盲法批次的3份冻存和1份新鲜样本。
主要发现
- 下一代QVOAs变异估计与QVOA相似。
- 超灵敏读数试验报告更高的感染单位/百万值。
- 批次内额外泊松变异为2.5倍(95%CI 2.1-3.5倍)。
- 实验室间变异增至3.4倍(95%CI 2.6-5.4倍)。
- 冻存未显著改变感染单位/百万值(-18%;95%CI -52%至39%)。
临床怎么用
- 下一代QVOAs可作为经典QVOA的可扩展替代,用于量化复制competent潜伏储存库,尤其在根除策略中需高通量和可扩展检测时。
局限性
- 样本量小(5名感染者+1名对照),仅单次白细胞分离样本,需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Evaluations of human immunodeficiency virus (HIV) curative interventions require reliable and efficient quantification of replication-competent latent reservoirs. The "classic" quantitative viral outgrowth assay (QVOA) has been regarded as the reference standard, although prohibitively resource and labor intensive. We compared 6 "next-generation" viral outgrowth assays, using polymerase chain reaction or ultrasensitive p24 to assess their suitability as scalable proxies for QVOA. METHODS: Next-generation QVOAs were compared with classic QVOA using single leukapheresis-derived samples from 5 antiretroviral therapy-suppressed HIV-infected participants and 1 HIV-uninfected control; each laboratory tested blinded batches of 3 frozen and 1 fresh sample. Markov chain Monte Carlo methods estimated extra-Poisson variation at aliquot, batch, and laboratory levels. Models also estimated the effect of testing frozen versus fresh samples. RESULTS: Next-generation QVOAs had similar estimates of variation to QVOA. Assays with ultrasensitive readout reported higher infectious units per million values than classic QVOA. Within-batch testing had 2.5-fold extra-Poisson variation (95% credible interval [CI], 2.1-3.5-fold) for next-generation assays. Between-laboratory variation increased extra-Poisson variation to 3.4-fold (95% CI, 2.6-5.4-fold). Frozen storage did not substantially alter infectious units per million values (-18%; 95% CI, -52% to 39%). CONCLUSIONS: The data offer cautious support for use of next-generation QVOAs as proxies for more laborious QVOA, while providing greater sensitivities and dynamic ranges. Measurement of latent reservoirs in eradication strategies would benefit from high throughput and scalable assays.
引用
- Stone M, Rosenbloom DIS, Bacchetti P, et al. Assessing the Suitability of Next-Generation Viral Outgrowth Assays to Measure Human Immunodeficiency Virus 1 Latent Reservoir Size. J Infect Dis. 2021. PMID: 32147687. doi:10.1093/infdis/jiaa089
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。